⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10538817 | 0.76 | — | — | |
| SCHEMBL2121756 | 0.74 | TP53 (0.33) | — | |
| SCHEMBL10697718 | 0.69 | — | — | |
| SCHEMBL2123571 | 0.69 | — | — | |
| SCHEMBL410013 | 0.69 | — | — | |
| SCHEMBL1828350 | 0.67 | — | — | |
| SCHEMBL793753 | 0.67 | — | — | |
| SCHEMBL29204873 | 0.67 | — | — | |
| SCHEMBL4640114 | 0.59 | TP53 (0.61) | — | |
| Isopropyl Alcohol SCHEMBL563810 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111057195-A | Cation modified slump-retaining type polycarboxylate superplasticizer and block polymerization method thereof | 浙江建设职业技术学院 | 2020-04-24 | — | — | CN | claimed |
| CN-111057197-A | Block polymerization and amide modification method of polycarboxylic slump retaining agent | 浙江建设职业技术学院 | 2020-04-24 | — | — | CN | claimed |
| US-20160296522-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-10-13 | — | — | US | claimed |
| CN-118076327-A | Topsheet system for absorbent article | 宝洁公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-103827304-B | Host cell and method for isobutanol production | 布特马斯先进生物燃料有限责任公司 | 2018-04-17 | — | — | CN | disclosed |
| WO-2016133832-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-25 | — | — | WO | disclosed |
| EP-2190839-B1 | A PROCESS FOR CHIRAL RESOLUTION OF 2-SUBSTITUTED 4-SUBSTITUTED 1,3-OXATHIOLANES | AVEXA LTD (AU) | 2015-04-15 | — | — | EP | disclosed |
| US-8318934-B2 | Process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes | AVEXA LIMITED (AU) | 2012-11-27 | — | — | US | disclosed |
| US-20100305321-A1 | PROCESS FOR CHIRAL RESOLUTION OF 2-SUBSTITUTED 4-SUBSTITUTED 1,3-OXATHIOLANES | AVEXA LIMITED (AU) | 2010-12-02 | — | — | US | disclosed |
| EP-2190839-A1 | A PROCESS FOR CHIRAL RESOLUTION OF 2-SUBSTITUTED 4-SUBSTITUTED 1,3-OXATHIOLANES | Avexa Limited (AU) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009039582-A1 | A PROCESS FOR CHIRAL RESOLUTION OF 2-SUBSTITUTED 4-SUBSTITUTED 1,3-OXATHIOLANES | AVEXA LIMITED (AU) | 2009-04-02 | — | — | WO | disclosed |
| EP-0315518-A1 | Cephalosporins having in position 3 a substituted vinyl radical, their process for preparation, their application as medicaments, compositions containing them and intermediates | ROUSSEL-UCLAF (FR) | 1989-05-10 | — | — | EP | disclosed |
| EP-0293771-A2 | Cephalosporin compound and pharmaceutical composition thereof | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1988-12-07 | — | — | EP | disclosed |